Sarcopenia Affects the Clinical Efficacy of Immune Checkpoint Inhibitors in Patients with Gastrointestinal Cancers

The impact of sarcopenia on the efficacy of immune checkpoint inhibitors (ICI) in gastrointestinal cancer (GIC) patients remains uncertain in clinical practice. Hence, this study aims to investigate the potential correlation between sarcopenia and the clinical outcomes of GIC patients treated with ICIs.
Source: Clinical Nutrition - Category: Nutrition Authors: Tags: Original article Source Type: research